Business Description
Fennec Pharmaceuticals is a North Carolina-based company focused on protecting cancer patients from hearing loss caused by cisplatin, a common chemotherapy drug. Its flagship product, PEDMARK, is approved to reduce this risk in children undergoing treatment and is distributed through pediatric cancer care networks across the United States. The company is also exploring whether this therapy can benefit older adolescents and adults through an ongoing partnership with Tampa General Hospital, while Norgine Pharma handles its commercial reach in other markets.
